Jain Deepti 4

What Happened Deepti Jain, a director of Treace Medical Concepts, Inc. (TMCI), was granted 30,000 restricted stock units (RSUs) on May 19, 2026. The award was recorded at $0.00 per share (total value $0 in cash); each RSU converts to one share of common stock upon vesting. This is a compensation/award transaction (not an open-market purchase or sale).

Key Details

• Transaction date: 2026-05-19 (reported on Form 4 filed May 19, 2026).
• Transaction type/code: Award/Grant (A).
• Amount: 30,000 RSUs; price reported $0.00 (non-cash grant).
• Vesting: RSUs vest 100% on the earlier of (a) May 19, 2027 or (b) the date of the 2027 annual meeting of stockholders, subject to continued service (Footnote F1).
• Footnotes: F1 explains one share per RSU and the vesting condition; F2 confirms the 30,000 RSUs.
• Shares owned after transaction: Not reported in this Form 4.
• Filing timeliness: No indication of a late filing in the report.

Context RSUs are deferred-compensation awards that convert into shares when they vest; they are not an immediate cash purchase or sale. Such grants are typically part of director or employee compensation and do not by themselves signal buying or selling intent. At vesting, shares may be subject to tax withholding or other company-specified deductions (not detailed in this filing).